FDA Comes Under Scrutiny

Health Affairs' Michael Gerber and Rob Lott discuss the latest developments at the FDA, including the first oral treatment for postpartum depression, the Accelerated Approval Program, and the agency being namechecked on the GOP presidential campaign trail.

Related Links:

• Create An Economic Incentive For The Timely Completion Of Confirmatory Trials (Health Affairs Forefront)
• The Conundrum Of Patient Access To Therapeutic Medical Devices (Health Affairs Forefront)
• FDA Approves First Oral Treatment for Postpartum Depression 
• Request For Abstracts - Reimagining Public Health
• Request For Abstracts - Perinatal Mental Health

Currently, more than 70 percent of our content is freely available — and we’d like to keep it that way. With your support, we can continue to keep our digital publication Forefront and podcasts free for everyone.

What is Health Affairs This Week?

Health Affairs This Week places listeners at the center of health policy’s proverbial water cooler. Join editors from Health Affairs, the leading journal of health policy research, and special guests as they discuss this week’s most pressing health policy news. All in 15 minutes or less.